Renal denervation and left ventricular mass regression: A benefit beyond blood pressure reduction?

Journal of the American College of Cardiology

Volumn 63, Issue 18, 2014, Pages 1924-1925

  Bakris, George ^a   Nathan, Sandeep ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

blood pressure; denervation; hypertension; ventricular mass

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LISINOPRIL; CALCIUM CHANNEL BLOCKING AGENT;

AMBULATORY MONITORING; BLOOD PRESSURE REGULATION; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; KIDNEY DENERVATION; NOTE; PRIORITY JOURNAL; RESISTANT HYPERTENSION; ADRENERGIC SYSTEM; AGE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DRUG RESPONSE; HEART LEFT VENTRICLE SIZE; MULTICENTER STUDY (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

BLOOD PRESSURE; DENERVATION; HYPERTENSION; VENTRICULAR MASS;

BLOOD PRESSURE; FEMALE; HEART RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; MALE; SYMPATHECTOMY;

EID: 84899813234     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.11.015     Document Type: Editorial

References (13)

1. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
2. P.A. Sarafidis, P. Georgianos, and G.L. Bakris Resistant hypertension - its identification and epidemiology Nat Rev Nephrol 9 2013 51 58
3. M.P. Schlaich, P.A. Sobotka, H. Krum, E. Lambert, and M.D. Esler Renal sympathetic-nerve ablation for uncontrolled hypertension N Engl J Med 361 2009 932 934
4. A.A. Thorp, R.N. Larsen, and M.P. Schlaich Renal sympathetic nerve ablation for the management of resistant hypertension: an update Curr Opin Nephrol Hypertens 22 2013 607 614
5. M.C. Brandt, F. Mahfoud, and S. Reda et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension J Am Coll Cardiol 59 2012 901 909
6. S.H. Schirmer, M.M.Y.A. Sayed, and J.-C. Reil et al. Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction J Am Coll Cardiol 63 2014 1916 1923
7. C. Rugale, Cailar G. Du, P. Fesler, J. Ribstein, G. Mourad, and A. Mimran Effect of early stage kidney disease on cardiac mass: comparison to post-donation renal function Am J Nephrol 38 2013 168 173
8. R.E. Schmieder, P. Martus, and A. Klingbeil Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies JAMA 275 1996 1507 1513
9. R.H. Fagard, H. Celis, L. Thijs, and S. Wouters Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies Hypertension 54 2009 1084 1091
10. A.B. Miller, N. Reichek, and S.M. St. John et al. Importance of blood pressure control in left ventricular mass regression J Am Soc Hypertens 4 2010 302 310
11. M.P. Schlaich, R.E. Schmieder, and G. Bakris et al. International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension J Am Coll Cardiol 62 2013 2031 2045
12. N. Pradhan, and N.F. Rossi Interactions between the sympathetic nervous system and angiotensin system in renovascular hypertension Curr Hypertens Rev 9 2013 121 129
13. G. Mancia, R. Dell'Oro, F. Quarti-Trevano, F. Scopelliti, and G. Grassi Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease J Hypertens Suppl 24 2006 S51 S56